Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0000950136-07-004881
Filing Date
2007-07-13
Accepted
2007-07-13 14:33:46
Documents
11
Period of Report
2006-12-31

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO FORM 10-K file1.htm 10-K/A 3622264
2 STOCK INCENTIVE PLAN file2.htm EX-10.1 170384
3 CERTIFICATE OF CHIEF EXECUTIVE OFFICER file3.htm EX-31.1 14267
4 CERTIFICATION OF CHIEF FINANCIAL OFFICER file4.htm EX-31.2 14160
5 CERTIFICATION OF CHIEF EXECUTIVE OFFICER file5.htm EX-32.1 5060
6 CERTIFICATION OF CHIEF FINANCIAL OFFICER file6.htm EX-32.2 5088
7 ebox.gif GRAPHIC 58
8 xbox.gif GRAPHIC 63
9 spacer.gif GRAPHIC 43
10 html_06137barchart.jpg GRAPHIC 17701
11 html_06137linechart.jpg GRAPHIC 20642
  Complete submission text file 0000950136-07-004881.txt   3886688
Mailing Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 21000
Business Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 21000 972-4-988-9488
Protalix BioTherapeutics, Inc. (Filer) CIK: 0001006281 (see all company filings)

EIN.: 650643773 | State of Incorp.: FL | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-33357 | Film No.: 07978420
SIC: 2836 Biological Products, (No Diagnostic Substances)